HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease.
about
Evasion of the Immune Response by Trypanosoma cruzi during Acute InfectionCD8+ T cells in Trypanosoma cruzi infectionModulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas diseaseChanges in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy.CD8(+) T cell-mediated immunity during Trypanosoma cruzi infection: a path for vaccine development?Methodological advances in drug discovery for Chagas disease.Presence of antigen-experienced T cells with low grade of differentiation and proliferative potential in chronic Chagas disease myocarditis.Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas diseaseChagasic patients are able to respond against a viral antigen from influenza virus.Chronic human infection with Trypanosoma cruzi drives CD4+ T cells to immune senescenceLow frequency of circulating CD8+ T stem cell memory cells in chronic chagasic patients with severe forms of the disease.Polyfunctional T cell responses in children in early stages of chronic Trypanosoma cruzi infection contrast with monofunctional responses of long-term infected adults.CD8+ T-cell responses to Theileria parva are preferentially directed to a single dominant antigen: Implications for parasite strain-specific immunity.Perturbed T cell IL-7 receptor signaling in chronic Chagas disease.Differential phenotypic and functional profiles of TcCA-2 -specific cytotoxic CD8+ T cells in the asymptomatic versus cardiac phase in Chagasic patients.Improved proteomic approach for the discovery of potential vaccine targets in Trypanosoma cruzi.Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives.Protective human leucocyte antigen haplotype, HLA-DRB1*01-B*14, against chronic Chagas disease in Bolivia.An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.Methodological approach to the ex vivo expansion and detection of T. cruzi-specific T cells from chronic Chagas disease patients.Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study.CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance.Chagas' disease: an update on immune mechanisms and therapeutic strategiesCD8+ T cells in Trypanosoma cruzi infection.New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice.Back to the future in Chagas disease: from animal models to patient cohort studies, progress in immunopathogenesis research.The chemistry and biology of trypanosomal trans-sialidases: virulence factors in Chagas disease and sleeping sickness.Dysfunctional adaptive immunity during parasitic infectionsTreatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell ResponsesLimited antigenic variation in the Trypanosoma cruzi candidate vaccine antigen TSA-1.Chagas disease immunogenetics: elusive markers of disease progression.Assessment of CD8(+) T cell differentiation in Trypanosoma cruzi-infected children.The Significance of Discordant Serology in Chagas Disease: Enhanced T-Cell Immunity to Trypanosoma cruzi in Serodiscordant Subjects.Specific activation of CD4- CD8- double-negative T cells by Trypanosoma cruzi-derived glycolipids induces a proinflammatory profile associated with cardiomyopathy in Chagas patients.Trypanosoma cruzi vaccine candidate antigens Tc24 and TSA-1 recall memory immune response associated with HLA-A and -B supertypes in Chagasic chronic patients from Mexico.Blocking of CD1d Decreases Trypanosoma cruzi-Induced Activation of CD4-CD8- T Cells and Modulates the Inflammatory Response in Patients With Chagas Heart Disease.Protective immunity against Trypanosoma cruzi.In vivo infection by Trypanosoma cruzi: The conserved FLY domain of the gp85/trans-sialidase family potentiates host infectionDistinct Treatment Outcomes of Antiparasitic Therapy in -Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell PhenotypesThe Unsolved Jigsaw Puzzle of the Immune Response in Chagas Disease
P2860
Q26772721-486D9C32-7705-4ADF-8B14-165A574C49CBQ28081766-C81EA933-A7D6-41C7-8599-BC0FE6E129A0Q28083346-820198BF-0258-44C6-92D9-31B7034D64BCQ33585491-43FAABBA-24AC-4949-9E09-9FC947AF32A1Q33914939-F05937FA-6DAF-4750-BA22-93BA56EB0968Q33945347-DE81C0D8-2712-441A-BD67-826244F41925Q34075123-A91BF753-5AC3-40EC-828D-2B6E9C173B1DQ34264559-0FE24CF1-EBF5-4ECE-A933-D590386ADB21Q34392873-EE9EFB94-FAEA-4188-8296-0038C448FBEEQ34783806-B3499857-6DC4-48B0-882F-E02A6C9C60FFQ34874190-D2CCE73A-984F-4BED-9E09-72575816076CQ35071204-D5254546-8BF6-4875-86E4-FF06C1D58E98Q35144260-100518BA-63C6-439D-AFDB-4637DB23FE59Q35348204-48B5088A-D005-4A1C-AFD8-ECF1517458A1Q35588670-214AD6FC-DCA9-449A-84A6-7A103C1456D6Q35660798-6284B54D-C5BF-407E-9349-8B5693CEDE37Q35810790-E68484BF-B7D4-4CE9-92AF-51DF45BDFEEAQ35842360-5C42F0DC-944B-4790-9B08-2D589AB5BC5BQ36256258-6C76A6D0-B9C8-43EA-BAD9-DAFF12BB9A61Q36383902-F4995F8E-B7C6-432B-881E-514444FA51A2Q36526649-669AEF63-AC1E-4AFE-BDA7-E91A13836FEBQ37200211-B41140FB-54C1-4B71-BAE2-028FB0D1218EQ37310959-D32081A7-BF5E-4FAF-8095-5B74F76AD8CBQ37326239-4AE042C1-4BC4-4B93-B8FC-98A4210A61A0Q37395315-FE6ACA6D-2E63-44BC-A486-262AD8A75017Q37597057-724302DC-5D04-4D6D-B4C3-ABAC0EDB9A3FQ37940361-4EF49456-C3FD-4C92-B758-6BF3FED3F1F3Q38212667-B0F5EEE4-113A-4BE8-8C1A-4280EA2F9FB6Q38871286-ECF7AEDF-43F4-4AC0-A03C-4A1943CE7EDAQ39141731-E1B19391-1285-40C5-8DEF-3D529E72855BQ39226738-CAC7F7A2-022F-4426-AA17-848DB6138FECQ40254337-BB14808B-984B-4C67-A248-49FD0B757838Q41665227-BFB9FB95-E9A6-451E-AE06-1FB36DB9271AQ48099205-0A537D5F-F52D-4830-82DD-3A4781D89991Q48149936-D4C7BB87-1921-4B39-B5D4-3EEAB62D43EBQ51669127-E0E38213-83C9-4EDC-BACE-9D9DA5F3F03AQ51890237-56F4F1C4-DD84-4650-9273-18EAD7346FCDQ57067394-F6CB4489-022C-49A7-A335-2B34DAB98F7DQ57110653-F66B4BBE-BE85-4BA9-A21A-4FF240456EE1Q58705710-01A908E4-2B42-4017-8FE8-0E773801A87E
P2860
HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
HLA Class I-T cell epitopes fr ...... lls in chronic Chagas disease.
@ast
HLA Class I-T cell epitopes fr ...... lls in chronic Chagas disease.
@en
type
label
HLA Class I-T cell epitopes fr ...... lls in chronic Chagas disease.
@ast
HLA Class I-T cell epitopes fr ...... lls in chronic Chagas disease.
@en
prefLabel
HLA Class I-T cell epitopes fr ...... lls in chronic Chagas disease.
@ast
HLA Class I-T cell epitopes fr ...... lls in chronic Chagas disease.
@en
P2093
P2860
P1476
HLA Class I-T cell epitopes fr ...... lls in chronic Chagas disease.
@en
P2093
Alejandro H Armenti
Carina Olivera
D Brent Weatherly
John Sidney
María C Albareda
María G Alvarez
Miriam Postan
Rick L Tarleton
Susana A Laucella
P2860
P356
10.1371/JOURNAL.PNTD.0000288
P407
P5008
P577
2008-09-03T00:00:00Z